本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Third Harmonic Bio, Inc.

5.38
0.0000
成交量:- -
成交额:- -
市值:2.43亿
市盈率:-4.32
高:5.38
开:5.38
低:5.38
收:5.38
52周最高:16.02
52周最低:3.18
股本:4,512.78万
流通股本:1,560.34万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.2457
每股收益(LYR):-1.0896
净资产收益率:-19.94%
总资产收益率:-14.60%
市净率:0.89
市盈率(LYR):-4.94

数据加载中...

2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/05

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans